Compliance SweepBack to stories →
← Back to stories
Governance & business operationsConditional reminder

FDA early alert: ButterflyBVM bag-valve-mask resuscitators, removal of lots 000109 to 000117 and pre-use test for others

The Food and Drug Administration (FDA) issued an Early Alert on November 3, 2026 about Compact Medical's "Urgent Medical Device Recall" for certain lots of ButterflyBVM single-use bag-valve-mask resuscitators: lots 000109 through 000117 are to be removed, and listed earlier lots get a correction, to perform the Pre-Use Test before every use and not use any unit that fails. A hole can form in the bellows, which FDA says can cause inadequate ventilation and hypoxia; the firm sent letters on September 26 and October 7, 2026.

The open back of an ambulance shows an airway bag with a clear resuscitation bag and mask on the stretcher.
Illustrative artwork; not evidence of the actual people, products or events described.

Current status

On November 15, 2026, the FDA Early Alert page showed content current as of November 3, 2026, the date it was issued, and FDA's list of medical device recalls and early alerts showed the item in a row dated 11/03/2026 with the status "Early Alert – FDA collecting information".

Who this affects

Hospitals, emergency medical services and any care area stocking ButterflyBVM single-use bag-valve-mask resuscitators (crash carts, code kits, transport).

Why it matters

If a hole develops in the bellows, tidal volume can leak from the device instead of reaching the patient; FDA says the leak can cause inadequate ventilation and hypoxia and, if not corrected, could result in serious injury or death. Clinical engineering, supply chain and respiratory therapy need to locate affected lots in every location (crash carts, kits, storage), replace removal lots only after a replacement bag-valve-mask (BVM) is in place, and add the pre-use test for correction lots. Inference: code-cart check lists may need a temporary step.

Required actions

  • None stated as a legal requirement; the firm's recommended actions are summarized on the FDA page (letters dated 2026-09-26 and 2026-10-07).

Scope and timing

Authority status
Other (Early Alert from FDA's Center for Devices and Radiological Health (CDRH) of a firm-initiated removal and correction)
Responsible owner
Clinical Engineering; Supply Chain; Respiratory Therapy
Publication date
2026-11-03
Other dates
Firm letters 2026-09-26 and 2026-10-07; injury status as of 2026-11-02

Not established

The firm's letters were not retained. The FDA page states no recall classification.

Earlier article: November 8, 2026 edition →

Sources

Complete edition and supplemental material

This article in the complete report →

Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.

Read the entire Compliance Sweep report →

← Return to stories

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies